Review on Diagnostic Criteria of Neurasthenia : Suggesting Pathway of Culture-bound dieases

  • Lee, Myeong Hun (Department of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Kim, Yunna (Department of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Cho, Seung-Hun (College of Korean Medicine, Kyung Hee University)
  • Received : 2017.11.21
  • Accepted : 2017.12.19
  • Published : 2017.12.31


Objective: Neurasthenia is a disease which consists of increased fatigue or bodily weakness and exhaustion plus pantalgia, dizziness, headache and other symtoms relevant to autonomic nerve dysfunction. There are plenty of studies investigating the history of diagnostic criteria of neurasthenia, which is influenced by diverse cultural(or social) environment. The obejective of this study is to provide review of the previous studys on the changes of neurasthenia diagnoses in the context of local area to find meanings of these transition and improve health care for psychiatric patient. Methods: Literature review was conducted on studies demonstrating diagnostic criteria of neurasthenia with cultural(or social) environment. We investigated the literature reviews or observative studies which described alteration of diagnostic criteria of neurasthenia and assessed its significance. After selecting eligible studies, the authors read the articles and summarized the meaningful contents those were significant in clinical practice. Results: Transformation of Chinese Classification of Mental Disorder(CCMD) integrated with internationally utilized DSM-IV or ICD-10 is controversial about its significance in that it had limited effect on public health care due to the variables of sociocultural context, but primarily differentiated neurasthenia from other disorders. The latter one can be the directing point of the diagnostic criteria of other culture-bound diseases, which is the traits of not outstanding mood(or affect) than other neurotic disorders. Conclusion: As diagnostic criteria of neurasthenia varies, the significance of this variation is controversial, but could be the paragon of other culture-bound diseases.


  1. Beard GM. A Practical Treatise on Nervous Exhaustion,(Neurasthenia;) Its Symptoms, Nature, Sequences, Treatment. American Journal of Psychiatry. 1880;36(4) :521-a-6.
  2. Beard GM. A practical treatise on nervous exhaustion (neurasthenia): its symptoms, nature, sequences, treatment. EB Treat; 1905.
  3. Flaskerud JH. Neurasthenia: here and there, now and then. Issues in mental health nursing. 2007;28(6):657-9.
  4. Lee S, Kleinman A. Are somatoform disorders changing with time? The case of neurasthenia in China. Psychosomatic medicine. 2007;69(9):846-9.
  5. Edition F, Association AP. Diagnostic and statistical manual of mental disorders. American Psychological Association, Washington Google Scholar. 1994.
  6. Organization WH. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization; 1992.
  7. Lee S, Tsang A, Zhang M-Y, Huang Y-Q, He Y-L, Liu Z-R, et al. Lifetime prevalence and inter-cohort variation in DSM-IV disorders in metropolitan China. Psychological medicine. 2007;37(1):61-71.
  8. Crocq MA. A history of anxiety: from Hippocrates to DSM. Dialogues in clinical neuroscience. 2015;17(3):319-25.
  9. Crocq MA. The history of generalized anxiety disorder as a diagnostic category. 11Dialogues in clinical neuroscience. 2017;19(2):107-16.
  10. Xiao S-F, Yan H-Q, Linden M, Korten A, Sartorius N. Recent developments in the study of prevalence and phenomenology of neurasthenia in general health care across cultures. Hong Kong Journal of Psychiatry. 1998;8(1):24.
  11. Association AP. Diagnostic and statistical manual of mental disorders (DSM-$5^{(R)}$). American Psychiatric Pub; 2013.
  12. Association AP. Diagnostic and Statistical Manual of Mental Health Disorders (DSM-III). American psychiatric association; 1980.
  13. Kleinman A. Neurasthenia and depression: a study of somatization and culture in China. Culture, medicine and psychiatry. 1982;6(2):117-90.
  14. Ming-Yuan Z. The diagnosis and phenomenology of neurasthenia a Shanghai study. Culture, medicine and psychiatry. 1989;13(2):147-61.
  15. Young D. Chinese Diagnostic Criteria and Case Examples of Mental Disorders. Hunan: Hunan University Press (in Chinese) Google Scholar. 1989.
  16. Chang DF, Myers HF, Yeung A, Zhang Y, Zhao J, Yu S. Shenjing shuairuo and the DSM-IV: diagnosis, distress, and disability in a Chinese primary care setting. Transcultural psychiatry. 2005;42(2):204-18.
  17. Shen Y-C, Zhang M-Y, Huang Y-Q, He Y-L, Liu Z-R, Cheng H, et al. Twelve-month prevalence, severity, and unmet need for treatment of mental disorders in metropolitan China. Psychological medicine. 2006;36(2):257-67.
  18. Fabrega H, Jr. The concept of somatization as a cultural and historical product of Western medicine. Psychosomatic medicine. 1990;52(6):653-72.
  19. Ying YW. Depressive symptomatology among Chinese-Americans as measured by the CES-D. Journal of clinical psychology. 1988;44(5):739-46.<739::AID-JCLP2270440512>3.0.CO;2-0
  20. Iwata N, Saito K, Roberts RE. Responses to a self-administered depression scale among younger adolescents in Japan. Psychiatry Research. 1994;53(3):275-87.
  21. Chung S-Y, Song S-Y, Kim J-W. Clinical guidelines for Hwabyung II.(Research on the Status of Hwabyung in Korea). Journal of Oriental Neuropsychiatry. 2013;24(spc1):15-22.
  22. Im C-S, Baeg S, Choi J-H, Lee M, Kim H-J, Chee I-S, et al. Comparative Analysis of Emotional Symptoms in Elderly Koreans with Hwa-Byung and Depression. 2017. 12
  23. Chen Y-F. Chinese classification of mental disorders (CCMD-3): towards integration in international classification. Psychopathology. 2002;35(2-3):171-5.